{
  "resourceType" : "CodeSystem",
  "id" : "ssf-1-leukemia-codesystem-cs",
  "language" : "zh-TW",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"zh-TW\" lang=\"zh-TW\"><p class=\"res-header-id\"><b>Generated Narrative: 代码系统 ssf-1-leukemia-codesystem-cs</b></p><a name=\"ssf-1-leukemia-codesystem-cs\"> </a><a name=\"hcssf-1-leukemia-codesystem-cs\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Language: zh-TW</p></div><p>This case-sensitive code system <code>https://www.ghd.tw/cdm-fhir/CodeSystem/ssf-1-leukemia-codesystem-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">000<a name=\"ssf-1-leukemia-codesystem-cs-000\"> </a></td><td>正常</td></tr><tr><td style=\"white-space:nowrap\">001<a name=\"ssf-1-leukemia-codesystem-cs-001\"> </a></td><td>AML with t(8;21)(q22;q22.1</td></tr><tr><td style=\"white-space:nowrap\">002<a name=\"ssf-1-leukemia-codesystem-cs-002\"> </a></td><td>AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)</td></tr><tr><td style=\"white-space:nowrap\">003<a name=\"ssf-1-leukemia-codesystem-cs-003\"> </a></td><td>Acute promyelocytic leukemia with t(15;17)</td></tr><tr><td style=\"white-space:nowrap\">004<a name=\"ssf-1-leukemia-codesystem-cs-004\"> </a></td><td>AML with t(9;11)(p21.3;q23.3)</td></tr><tr><td style=\"white-space:nowrap\">005<a name=\"ssf-1-leukemia-codesystem-cs-005\"> </a></td><td>AML with t(6;9)(p23;q34.1)</td></tr><tr><td style=\"white-space:nowrap\">006<a name=\"ssf-1-leukemia-codesystem-cs-006\"> </a></td><td>AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)</td></tr><tr><td style=\"white-space:nowrap\">007<a name=\"ssf-1-leukemia-codesystem-cs-007\"> </a></td><td>AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)</td></tr><tr><td style=\"white-space:nowrap\">013<a name=\"ssf-1-leukemia-codesystem-cs-013\"> </a></td><td>AML with t(9;22)(q34;q11)</td></tr><tr><td style=\"white-space:nowrap\">021<a name=\"ssf-1-leukemia-codesystem-cs-021\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">022<a name=\"ssf-1-leukemia-codesystem-cs-022\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">023<a name=\"ssf-1-leukemia-codesystem-cs-023\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)</td></tr><tr><td style=\"white-space:nowrap\">024<a name=\"ssf-1-leukemia-codesystem-cs-024\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hyperdiploidy</td></tr><tr><td style=\"white-space:nowrap\">025<a name=\"ssf-1-leukemia-codesystem-cs-025\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)</td></tr><tr><td style=\"white-space:nowrap\">026<a name=\"ssf-1-leukemia-codesystem-cs-026\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)</td></tr><tr><td style=\"white-space:nowrap\">027<a name=\"ssf-1-leukemia-codesystem-cs-027\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)</td></tr><tr><td style=\"white-space:nowrap\">041<a name=\"ssf-1-leukemia-codesystem-cs-041\"> </a></td><td>Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">042<a name=\"ssf-1-leukemia-codesystem-cs-042\"> </a></td><td>Mixed phenotype acute leukemia with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">051<a name=\"ssf-1-leukemia-codesystem-cs-051\"> </a></td><td>Chronic myelogenous leukemia，t(9;22)</td></tr><tr><td style=\"white-space:nowrap\">061<a name=\"ssf-1-leukemia-codesystem-cs-061\"> </a></td><td>Myelodysplastic syndrome associated with isolated del(5q-)</td></tr><tr><td style=\"white-space:nowrap\">090<a name=\"ssf-1-leukemia-codesystem-cs-090\"> </a></td><td>(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">091<a name=\"ssf-1-leukemia-codesystem-cs-091\"> </a></td><td>同時有兩種上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">092<a name=\"ssf-1-leukemia-codesystem-cs-092\"> </a></td><td>複雜之染色體異常，指三項(含)以上的染色體變化者</td></tr><tr><td style=\"white-space:nowrap\">8XX<a name=\"ssf-1-leukemia-codesystem-cs-8XX\"> </a></td><td>Chromosome study after chemotherapy or immunotherapy or target therapy</td></tr><tr><td style=\"white-space:nowrap\">988<a name=\"ssf-1-leukemia-codesystem-cs-988\"> </a></td><td>不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)</td></tr><tr><td style=\"white-space:nowrap\">998<a name=\"ssf-1-leukemia-codesystem-cs-998\"> </a></td><td>有執行染色體檢查，但結果無法判斷</td></tr><tr><td style=\"white-space:nowrap\">999<a name=\"ssf-1-leukemia-codesystem-cs-999\"> </a></td><td>病歷未記載或不詳或未執行染色體檢查</td></tr></table></div>"
  },
  "url" : "https://www.ghd.tw/cdm-fhir/CodeSystem/ssf-1-leukemia-codesystem-cs",
  "version" : "1.1.0",
  "name" : "SSF1leukemiaCS",
  "title" : "SSF1 白血病-白血病染色體檢查的評估代碼系統",
  "status" : "active",
  "experimental" : false,
  "date" : "2024-08-01T15:33:47+08:00",
  "publisher" : "國家衛生研究院",
  "contact" : [{
    "name" : "國家衛生研究院",
    "telecom" : [{
      "system" : "url",
      "value" : "https://ghd.tw/"
    }]
  }],
  "description" : "Assessment of chromosome study in leukemia Code System",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "TW"
    }]
  }],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 27,
  "concept" : [{
    "code" : "000",
    "display" : "正常"
  },
  {
    "code" : "001",
    "display" : "AML with t(8;21)(q22;q22.1"
  },
  {
    "code" : "002",
    "display" : "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)"
  },
  {
    "code" : "003",
    "display" : "Acute promyelocytic leukemia with t(15;17)"
  },
  {
    "code" : "004",
    "display" : "AML with t(9;11)(p21.3;q23.3)"
  },
  {
    "code" : "005",
    "display" : "AML with t(6;9)(p23;q34.1)"
  },
  {
    "code" : "006",
    "display" : "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)"
  },
  {
    "code" : "007",
    "display" : "AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)"
  },
  {
    "code" : "013",
    "display" : "AML with t(9;22)(q34;q11)"
  },
  {
    "code" : "021",
    "display" : "B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)"
  },
  {
    "code" : "022",
    "display" : "B lymphoblastic leukemia / lymphoma with t(v;11q23.3)"
  },
  {
    "code" : "023",
    "display" : "B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)"
  },
  {
    "code" : "024",
    "display" : "B lymphoblastic leukemia / lymphoma with hyperdiploidy"
  },
  {
    "code" : "025",
    "display" : "B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)"
  },
  {
    "code" : "026",
    "display" : "B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)"
  },
  {
    "code" : "027",
    "display" : "B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)"
  },
  {
    "code" : "041",
    "display" : "Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)"
  },
  {
    "code" : "042",
    "display" : "Mixed phenotype acute leukemia with t(v;11q23.3)"
  },
  {
    "code" : "051",
    "display" : "Chronic myelogenous leukemia，t(9;22)"
  },
  {
    "code" : "061",
    "display" : "Myelodysplastic syndrome associated with isolated del(5q-)"
  },
  {
    "code" : "090",
    "display" : "(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常"
  },
  {
    "code" : "091",
    "display" : "同時有兩種上述之染色體異常"
  },
  {
    "code" : "092",
    "display" : "複雜之染色體異常，指三項(含)以上的染色體變化者"
  },
  {
    "code" : "8XX",
    "display" : "Chromosome study after chemotherapy or immunotherapy or target therapy"
  },
  {
    "code" : "988",
    "display" : "不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)"
  },
  {
    "code" : "998",
    "display" : "有執行染色體檢查，但結果無法判斷"
  },
  {
    "code" : "999",
    "display" : "病歷未記載或不詳或未執行染色體檢查"
  }]
}